Literature DB >> 9743609

Human neutrophils express the interleukin-15 receptor alpha chain (IL-15Ralpha) but not the IL-9Ralpha component.

D Girard1, N Boiani, A D Beaulieu.   

Abstract

The interleukin-15 receptor (IL-15R) is composed of at least three chains, namely gammac, IL-2Rbeta, and the recently identified IL-15Ralpha, while the IL-9R complex consists of gammac and a subunit designated IL-9Ralpha. Our previous work and that of others have shown that human neutrophils express gammac and IL-2Rbeta (two components shared with IL-2R) but not IL-2Ralpha and that IL-15 is a neutrophil agonist, whereas IL-2 is not. In this study, using flow cytometry with a specific anti-human IL-15Ralpha, we show for the first time that human neutrophils express surface IL-15Ralpha. Although we previously found that IL-15 is a neutrophil agonist, our present work shows that IL-15 does not trigger superoxide production nor cell spreading onto glass. In addition, we report that human neutrophils do not respond to IL-9 with respect to the functions/responses studied, namely, superoxide production, spreading onto glass, cell shape changes, phagocytosis, RNA synthesis, and apoptosis. Further, our results show that neutrophils do not express IL-9Ralpha as assessed by flow cytometry with a specific anti-human IL-9Ralpha antibody that stains the transfected cell line BW-h9R used as positive control. Finally, our results indicate that gammac expression was not modulated and remained stable for up to 24 h when neutrophils were stimulated with all currently known "gammac users," namely, IL-2, IL-4, IL-7, IL-9, and IL-15. We conclude that human neutrophils express all IL-15R components on their surface, including IL-15Ralpha, that IL-15 activates human neutrophils (as the IL-4 neutrophil agonist) by a mechanism which does not involve upregulation of gammac cell surface expression, and that IL-9 is not a neutrophil agonist as demonstrated by the inability to modulate the tested functions/responses that correlate with lack of the IL-9R component, namely, IL-9Ralpha. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9743609     DOI: 10.1006/clin.1998.4576

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  5 in total

Review 1.  The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use.

Authors:  Pin-Yu Perera; Jack H Lichy; Thomas A Waldmann; Liyanage P Perera
Journal:  Microbes Infect       Date:  2011-10-25       Impact factor: 2.700

2.  Interleukin-15 increases neutrophil adhesion onto human respiratory epithelial A549 cells and attracts neutrophils in vivo.

Authors:  M Pelletier; D Girard
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

3.  Human peripheral neutrophils express functional IL-21 receptors.

Authors:  Yuji Takeda; Hidetoshi Nara; Akemi Araki; Hironobu Asao
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

Review 4.  Role of interleukin-15 in cardiovascular diseases.

Authors:  Lei Guo; Ming-Fei Liu; Ji-Niu Huang; Jia-Min Li; Jun Jiang; Jian-An Wang
Journal:  J Cell Mol Med       Date:  2020-05-14       Impact factor: 5.310

5.  Lupus serum induces inflammatory interaction with neutrophils in human glomerular endothelial cells.

Authors:  Dayvia A Russell; Margaret Markiewicz; Jim C Oates
Journal:  Lupus Sci Med       Date:  2020-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.